Related Experiment Videos
[Ventricular tachyarrhythmias treated with berberine].
1Shanghai Xu Hui District Central Hospital.
Zhonghua Xin Xue Guan Bing Za Zhi
|June 1, 1990
Summary
Berridine effectively suppresses ventricular tachyarrhythmias, significantly reducing ventricular premature contractions (VPCs) in patients. This natural compound shows promise with minimal side effects for managing heart rhythm disorders.
Area of Science:
- Cardiology
- Pharmacology
- Natural Products
Context:
- Ventricular tachyarrhythmias pose a significant risk for cardiovascular events.
- Ambulatory monitoring is crucial for assessing arrhythmia burden.
- Evaluating natural compounds for arrhythmia management is an active research area.
Purpose:
- To investigate the efficacy of berberine in treating ventricular tachyarrhythmias.
- To quantify the reduction in ventricular premature contractions (VPCs) with berberine treatment.
Summary:
- Berberine demonstrated significant efficacy in a study of 100 patients with ventricular tachyarrhythmias.
- A 50% or greater VPC suppression was observed in 62% of patients, with 38% achieving 90% or greater suppression.
- Mean VPCs decreased from 452 to 271 beats per hour (P < 0.001), indicating a statistically significant reduction.
Impact:
- Berberine is a potentially effective therapeutic agent for ventricular tachyarrhythmias.
- The study suggests berberine offers a favorable safety profile, with only mild gastrointestinal symptoms reported.
- These findings support further research into berberine for cardiac rhythm management.